Series date: 
01/01/2023 - 7:00am CST to 12/30/2023 - 11:59pm CST

OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Evaluate the ATA and NCCN guidelines on how they are utilizing in the practice of treating endocrine tumors, (2) Examine and state differences in pathology and image of diverse tumors.

PLANNER/MODERATOR DISCLOSURE:  Raphaella Vallera, MD, and Christine Landry, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Tarah Brown at Tarah.Brown@BSWHealth.org

 

Series location: 
Baylor Charles A. Sammons Cancer Center - Dallas Campus
3410 Worth Street Ste 580
Dallas 75246
United States

Sessions

Session Date
YYYYMMDD Dallas Endocrine TB TEMPLATE 01/17/2023 - 7:00am to 8:00am CST
20230117 Dallas Endocrine TB 01/17/2023 - 7:00am to 8:00am CST
20230221 Dallas Endocrine TB 02/21/2023 - 7:00am to 8:00am CST
CANCELLED 20230321 Dallas Endocrine TB 03/21/2023 - 7:00am to 8:00am CDT
2023418 Dallas Endocrine TB 04/18/2023 - 7:00am to 8:00am CDT
20230516 Dallas Endocrine TB 05/16/2023 - 7:00am to 8:00am CDT
20230620 Dallas Endocrine TB 06/20/2023 - 7:00am to 8:00am CDT
20230718 Dallas Endocrine TB 07/18/2023 - 7:00am to 8:00am CDT
20230815 Dallas Endocrine TB 08/15/2023 - 7:00am to 8:00am CDT
20230919 Dallas Endocrine TB 09/19/2023 - 7:00am to 8:00am CDT

Pages